Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy.

Fabio Tramuto, Elena Pariani, Marzia Facchini, Laura Calzoletti, Donatella Tiberti, Angela Di Martino, Stefania Bellino, Tolinda Gallo, Elisabetta Pagani, Giuseppina Di Mario, Lucio Romano, Anna Tosti, Bernhard Natter, Sabrina Senatore, Enrico Volpe, Pierlanfranco D’Agaro, Ornella Punzo, Simona Puzelli, Maria Grazia Pascucci, Pierina Rita TanchisVittorio Di Carlo, Elisabetta Pagani, Paola Affanni, Simone Giannecchini, Maria Chironna, Concetta Fabiani, Valeria Ghisetti, Cinzia Germinario, Antonino Bella, Patrizio Pezzotti, Maria Rita Castrucci, Caterina Serra, Barbara Camilloni

Risultato della ricerca: Articlepeer review

5 Citazioni (Scopus)

Abstract

Background: Influenza vaccines are updated every year to match the vaccine strains with currently circulating viruses; consequently influenza vaccine effectiveness (IVE) has to be assessed annually.Research design and methods: A test-negative case-control study was conducted within the context of the Italian sentinel influenza surveillance network to estimate IVE by age group, virus subtype, and vaccine brand in medically attended laboratory-confirmed influenza.Results: In Italy, the 2018/19 influenza season was characterized by the co-circulation of influenza A(H1N1)pdm09 and A(H3N2) viruses. The adjusted IVE estimate in preventing influenza was moderate (44.8%, 95% CI: 18.8 to 62.5) against A(H1N1)pdm09, whereas there was no evidence of effectiveness (1.8%, 95% CI: -37.8 to 30.1) in persons affected by A(H3N2). IVE against A(H1N1)pdm09 decreased with age ranging from 65.7% to 13.1% among children/adolescents and elderly, respectively; moreover results suggest that Vaxigrip Tetra® was more effective against A(H1N1)pdm09 compared to Fluarix Tetra® [62.5% (95% CI: 34.3 to 78.6) vs 24.5% (95% CI: -40.6 to 59.6)]. Low effectiveness (35.2%, 95% CI: -50.8 to 72.1) against A(H3N2) was detected only in the elderly immunized with Fluad®.Conclusions: Findings suggest that influenza vaccines were low to moderately effective, probably due to a mismatch between circulating and vaccine strains.
Lingua originaleEnglish
pagine (da-a)1201-1209
Numero di pagine9
RivistaExpert Review of Vaccines
Volume18
Stato di pubblicazionePublished - 2019

All Science Journal Classification (ASJC) codes

  • Immunology
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Fingerprint Entra nei temi di ricerca di 'Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy.'. Insieme formano una fingerprint unica.

Cita questo